Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The aim of this phase II trial is asses the tolerability and the effectiveness of imatinib in patients with chronic myelogenous leukemia in chronic phase with age more than 70, diagnosis of cml is being performed within 1 year. Quality of life will be carefully assessed.
Critère d'inclusion
- Chronic myeloid leukemia